Forums before death by AOL, social media and spammers... "We can't have nice things"
|    sci.med.psychobiology    |    Dialog and news in psychiatry and psycho    |    4,734 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 3,764 of 4,734    |
|    =?UTF-8?B?4oqZ77y/4oqZ?= to All    |
|    US Opioid Epidemic Fueled by Prescribing    |
|    02 Oct 15 05:25:24    |
      From: deputydog23x@gmail.com                              NEWS & PERSPECTIVE › MULTISPECIALTY                     US Opioid Epidemic Fueled by Prescribing Practices       Pam Harrison       September 28, 2015               The United States is facing the worst "man-made epidemic" of opioid abuse in       the history of modern medicine, and it is the direct result of poor research       and outdated teaching practices, according to a leading pain expert.              "There's been over 200,000 deaths from prescription opioids and many more       hundreds of thousands of overdose admissions, and millions are addicted or       dependent on prescription opioids, and while some patients don't meet the       classic definition of opioid        use disorder, as many as 30% of patients who are sitting across from you in       your office have opioid use disorder or are severely dependent," Gary       Franklin, MD, MPH, vice president of Physicians for Responsible Opioid       Prescribing, said during a Webinar        sponsored by the Centers for Disease Control and Prevention's Clinician       Outreach and Communication Activity (COCA).              "So this is an extremely serious epidemic, and while I know that taking care       of these patients is not an easy thing to do, we need to reduce overdose       deaths and admissions, and we have ways to reverse trends which we all need to       embrace."              The most important step toward reversing the epidemic of prescription opioid       abuse is to stop prescribing opioids for the wrong indications.              Recent reports have consistently concluded that there are insufficient data on       the long-term effectiveness of prescription opioids to support their use in       the treatment of chronic pain, but there is clear evidence of a dose-dependent       risk for serious        harms.              The biggest triggers to the initiation and perpetuation of prescription opioid       abuse comes from their use for the treatment of nonspecific musculoskeletal       disorders, especially chronic low back pain, headaches, and disorders such as       fibromyalgia.              Although there is no proven benefit for their use in these disorders, "people       with these indications are on chronic opioids, and they have become disabled,       and they are spilling over into social security and disability systems," Dr       Franklin said.              In recognition of this problem, the American Academy of Neurology and a number       of states, including Washington, have produced guidelines that advise that in       general, opioids should not be routinely used for the treatment of       musculoskeletal conditions,        headache, or fibromyalgia.              "Not only is there no evidence to support their use in these conditions, there       is quite a bit of evidence against doing so, and these are probably the most       routine patients we have who are on chronic opioids and who have become       dependent and addicted to        them in our country," Dr Franklin said.              Indeed, in a 2008 study conducted by Dr Franklin and colleagues (Spine.       2008;33:199-204), results showed that 14% of workers who sustained a low back       injury were disabled at 1 year and that receiving opioids for at least 7 days       at a cumulative dose of        150 mg morphine equivalent dose (MED) doubled the risk of being on disability       1 year later, after adjusting for baseline reported pain, function, and injury       severity.              Dosing Guidance              The issue of the MED and the risk for an overdose event, either        ospitalization or death, is also extremely important in community efforts to       reduce the risk for opioid-induced harm.              Recent evidence suggests that there is a dramatic increase in death when       opioids are administered at a dose of 100 mg MED ― "but the risk of overdose       is also two- to fivefold higher when that same opioid MED runs between 50 and       99 mg MED," Dr Franklin        said.              "So you need to be paying a lot more attention to lower doses of opioids and       never go over 100 mg MED."              This is particularly important for patients who are receiving a combination of       an opioid and either a benzodiazepine or another sedative-hypnotic or muscle       relaxants, all of which can dramatically add to the risk for opioid harm, even       at lower doses of        opioids, he added.              Dr Franklin also cautioned that the intermittent use of opioids does not spare       patients from overdose and that in doses lower than 100 mg MED, many patients       enrolled in Washington State's Medicaid program have been admitted for opioid       overdose even when        they were not using opioids on a long-term basis.              Comprehensive guidelines from Washington State on prescribing opioids make it       very clear that physicians must proceed with caution when initiating opioid       therapy to improve function and pain in patients with chronic pain or when       transitioning to the long-       term use of opioids.              Before initiating treatment with any opioid, patients should be screened for       current or past substance abuse as well as depression.              Clinically Meaningful Improvement              "When you are tracking pain and function, you also have to make sure there is       clinically meaningful improvement in both pain and function," said Dr Franklin.              In Washington State, a clinically meaningful improvement in pain and function       means at least a 30% improvement in both.              Physicians also need to track pain and function at every visit so that they       can better judge how well the opioid may be working — or not.              Sleep disturbances are common in patients with chronic pain, and physicians       need to help patients with various measures to improve sleep hygiene or       prescribe a tricyclic antidepressant, which will help with underlying       depression as well sleep        disturbances, he added.              There are also many nonpharmacologic alternatives to long-term opioid use that       are strongly supported by evidence.              Graded exercise is well established as a good treatment modality for chronic       pain, as are cognitive-behavioral therapy (CBT), mindfulness-based stress       reduction techniques, and various forms of meditation and yoga.              If patients who are currently receiving opioids are scheduled for an elective       operation, they should resume their preoperative dose of opioids 6 weeks after       surgery.              If they are not receiving opioids at the time of the procedure, patients       should be off all opioids within 6 weeks.              And if patients are not improving on opioid therapy, "the ongoing risk from       continued treatment outweighs the benefit," Dr Franklin said.              "And opioids in these patients should be tapered to zero."              The new guidelines indicate that when tapering opioids, the dose should be       reduced by 10% a week, with or without accompanying CBT, inpatient       detoxification, or treatment in a pain clinic.                     [continued in next message]              --- SoupGate-Win32 v1.05        * Origin: you cannot sedate... all the things you hate (1:229/2)    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca